Annette North
2019 - Turning Point Therapeutics
In 2019, Annette North earned a total compensation of $3.1M as Former Executive Vice President and General Counsel at Turning Point Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $173,400 |
|---|---|
| Option Awards | $2,628,672 |
| Salary | $272,708 |
| Other | $9,500 |
| Total | $3,084,280 |
North received $2.6M in option awards, accounting for 85% of the total pay in 2019.
North also received $173.4K in non-equity incentive plan, $272.7K in salary and $9.5K in other compensation.
Rankings
In 2019, Annette North's compensation ranked 3,977th out of 13,971 executives tracked by ExecPay. In other words, North earned more than 71.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,977 out of 13,971 | 72nd |
Division Manufacturing | 1,434 out of 5,701 | 75th |
Major group Chemicals And Allied Products | 506 out of 2,200 | 77th |
Industry group Drugs | 427 out of 1,886 | 77th |
Industry Pharmaceutical Preparations | 325 out of 1,398 | 77th |
Source: SEC filing on April 29, 2022.
North's colleagues
We found three more compensation records of executives who worked with Annette North at Turning Point Therapeutics in 2019.